Related references
Note: Only part of the references are listed.Regulation of immunological tolerance by the p53-inhibitor iASPP
Elliot H. H. Akama-Garren et al.
CELL DEATH & DISEASE (2023)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis
Yuki Homma et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2022)
Mutant Ras and inflammation-driven skin tumorigenesis is suppressed via a JNK-iASPP-AP1 axis
Khatoun Al Moussawi et al.
CELL REPORTS (2022)
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes
Michael Eyres et al.
GASTROENTEROLOGY (2021)
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Liwei Cao et al.
CELL (2021)
Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis
Sophie Liot et al.
SCIENTIFIC REPORTS (2021)
JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer
E. Josue Ruiz et al.
JCI INSIGHT (2021)
Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer
Linara Gabitova-Cornell et al.
CANCER CELL (2020)
Molecular subtypes of pancreatic cancer
Eric A. Collisson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition
Shuo Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy
Bo Kong et al.
GUT (2018)
TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions
Heonjong Han et al.
NUCLEIC ACIDS RESEARCH (2018)
Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas
Isidoro Cobo et al.
NATURE (2018)
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
Francesco Puleo et al.
GASTROENTEROLOGY (2018)
Acinar cell plasticity and development of pancreatic ductal adenocarcinoma
Peter Storz
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis
Xiangrong Liu et al.
TUMOR BIOLOGY (2016)
RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis
Marina Lesina et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer
Stephan Kruger et al.
PANCREATOLOGY (2016)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy
Min Lu et al.
FEBS LETTERS (2014)
Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRasG12V-driven pancreatic tumourigenesis
Marta Flandez et al.
GUT (2014)
Nuclear iASPP may facilitate prostate cancer progression
E. V. Morris et al.
CELL DEATH & DISEASE (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP
Min Lu et al.
CANCER CELL (2013)
Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
Tomer Cooks et al.
CANCER CELL (2013)
Models of Acute and Chronic Pancreatitis
Markus M. Lerch et al.
GASTROENTEROLOGY (2013)
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Christine M. Ardito et al.
CANCER CELL (2012)
Genetically Engineered Mouse Models of Pancreatic Cancer
Christoph Benedikt Westphalen et al.
CANCER JOURNAL (2012)
iASPP and Chemoresistance in Ovarian Cancers: Effects on Paclitaxel-Mediated Mitotic Catastrophe
LiLi Jiang et al.
CLINICAL CANCER RESEARCH (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification
Mario Notari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inflammatory cells regulate p53 and caspases in acute pancreatitis
Yuji Nakamura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection
Sara Raimondi et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
The waved with open eyelids (woe) Locus Is a Hypomorphic Mouse Mutation in Adam17
E. L. Hassemer et al.
GENETICS (2010)
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Jennifer P. Morton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells
Lilach Weisz et al.
CANCER RESEARCH (2007)
Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates
AL Means et al.
DEVELOPMENT (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
A mutation in NFkB interacting protein 1 results in cardiomyopathy and abnormal skin development in wa3 mice
BJ Herron et al.
HUMAN MOLECULAR GENETICS (2005)
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes
A Willis et al.
ONCOGENE (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray
A Maitra et al.
MODERN PATHOLOGY (2003)
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human
D Bergamaschi et al.
NATURE GENETICS (2003)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Share Paper
